Skip to main content

Prof. Dr. Andreas Zimmer

Member, Steering-Committee Member

Institute of Molecular Psychiatry (IMP)

Medical Faculty, University of Bonn University Hospital of Bonn Sigmund Freud Strasse 25 53127 Bonn

neuro@uni-bonn.de

+49 228 6885304

Website

Prof. Zimmer and his groups are interested in the molecular mechanisms of neuropsychiatric disorders with a focus on addiction, pain and affective disorders, molecular biology of modulatory neurotransmitters, and the molecular biology of aging.

Recent publications

  • Fatty-acid amide hydrolase inhibition mitigates Alzheimer's disease progression in mouse models of amyloidosis.

    The FEBS journal

    Authors: Sergio Oddi, Lucia Scipioni, Antonio Totaro, Giacomo Giacovazzo, Francesca Ciaramellano, Daniel Tortolani, Alessandro Leuti, Rita Businaro, Federica Armeli, Andras Bilkei-Gorzo, Roberto Coccurello, Andreas Zimmer, Mauro Maccarrone

    View this publication
  • The endocannabinoid anandamide mediates anti-inflammatory effects through activation of NR4A nuclear receptors.

    British journal of pharmacology

    Authors: Tom Teichmann, Beatrice Pflüger-Müller, Virna Margarita Martín Giménez, Fiona Sailer, Henrik Dirks, Simonida Zehr, Timothy Warwick, Felix Brettner, Paola Munoz-Tello, Andreas Zimmer, Irmgard Tegeder, Dominique Thomas, Robert Gurke, Stefan Günther, Jan Heering, Ewgenij Proschak, Gerd Geisslinger, Iris-S Bibli, Dagmar Meyer Zu Heringdorf, Walter Manucha, Maike Windbergs, Stefan Knapp, Andreas Weigert, Matthias S Leisegang, Douglas Kojetin, Ralf P Brandes

    View this publication
  • Differential temporal decline of cerebral oxytocin and μ-opioid receptor density during the aging process in mice.

    The European journal of neuroscience

    Authors: Felix Effah, Prakash Nidadavolu, Nívea Karla de Gusmão Taveiros Silva, Milosz Wojtowicz, Rosana Camarini, Andreas Zimmer, Alexis Bailey

    View this publication